Hutch News

Hutch News

Stories tagged 'hormone therapy'

Your cancer sex Rx

Expert tips, tools and tricks to help you reboot your post-cancer body and rekindle intimacy after cancer treatment

July 29, 2016 | By Diane Mapes / Fred Hutch News Service

Cancer treatment can have a profound impact on all aspects of a person's life -- including their sex life. Our experts offer practical tips, tools and tricks to help those who've been through treatment rekindle intimacy after cancer.

View story >

Fred Hutch researchers tackle hot flashes

New study finds antidepressant nearly as effective as low-dose estrogen for cutting back hot flash frequency

May 26, 2014 | By Diane Mapes

Life in the menopause lane can be a frustrating succession of temperature (and wardrobe) changes as fickle, 50-something bodies flit from one extreme to the other.

View story >

Intermittent hormone therapy for prostate cancer inferior to continuous therapy

Cathy Tangen contributes to international study, finding on again-off again prostate cancer treatment has quality of life benefits, but continuous therapy improves overall survival

June 4, 2012

Many men with metastatic, hormone-sensitive prostate cancer live longer on continuous androgen-deprivation therapy (also known as hormone therapy) than on intermittent therapy, according to a 17-year study led by SWOG (formerly Southwest Oncology Group), a cancer research cooperative group.

View story >

PET scans confirm effectiveness of estrogen-blocking therapy

SCCA study findings have implications for personalized breast cancer treatment and drug development

Aug. 29, 2011 | By Dean Forbes

For the first time, researchers at Seattle Cancer Care Alliance have demonstrated the feasibility of using serial positron emission tomography (PET) scans, using a special estrogen-containing isotope, to confirm the relative effectiveness of estrogen-blocking and estrogen-depleting therapy in patients with metastatic breast cancer.

View story >

Postmenopausal estrogen use brings both benefits, risks

Longer-term Women’s Health Initiative follow-up of estrogen therapy users finds reduced risk of breast cancer, decreased heart disease in younger women

April 11, 2011

Strokes and other health problems linked with estrogen pills appear to fade when women quit taking them after menopause, a long-term follow-up study from the landmark Women’s Health Initiative has found. The findings also confirm that concerns about breast cancer and heart attacks are largely unfounded for those who take the hormone for a short period of time to relieve hot flashes and other menopause symptoms.

View story >

Two Center scientists receive new investigator awards

Bielas, Mostaghel secure three-year funding for prostate-cancer research

Dec. 7, 2009 | By Colleen Steelquist

Fred Hutchinson Cancer Research Center Drs. Elahe Mostaghel and Jason Bielas recently received New Investigator Awards from the Department of Defense’s Prostate Cancer Research Program.

View story >

(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks


Support our quest for cures

Story Archive


Magazine Archive
Back issues of Hutch Magazine

Financial Reporting
Fiscal highlights & Annual Reports

Science Spotlight
Monthly review of Center-authored papers

Fred Hutch News

        Get updates via email.